Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 8, 2009
The dopamine D(2) receptor partial agonist aplindore improves motor deficits in MPTP-treated common marmosets alone and combined with L-dopaMichael John Jackson, Terrance H Andree, Matthew Hansard, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 12, 2005
WAY-163909 [(7bR, 10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole], a novel 5-hydroxytryptamine 2C receptor-selective agonist with anorectic activityJohn Dunlop, Annmarie L Sabb, Hossein Mazandarani, et al.
European Journal of Pharmacology|October 24, 2006
Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonistJulia N Heinrich, Julie Brennan, Margaret H Lai, et al.
BMC Family Practice|February 7, 2020
The University of Limerick Education and Research Network for General Practice (ULEARN-GP): practice characteristics and general practitioner perspectivesAndrew O'Regan, Peter Hayes, Ray O'Connor, et al.
American Journal of Clinical Pathology|June 30, 2025
Establishment of the Veterans Affairs SeqFORCE (Sequencing for Research Clinical and Epidemiology) program for SARS-CoV-2 whole-genome sequencingMark Holodniy, Ying Pei, Gary Stack, et al.
Psychopharmacology|February 14, 2007
Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodentsSharon Rosenzweig-Lipson, Annmarie Sabb, Gary Stack, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 16, 2011
Characterization of vabicaserin (SCA-136), a selective 5-hydroxytryptamine 2C receptor agonistJohn Dunlop, Stephanie W Watts, James E Barrett, et al.
Irish Journal of Medical Science|May 29, 2020
Career destinations of graduates from a medical school with an 18-week longitudinal integrated clerkship in general practice: a survey of alumni 6 to 8 years after graduationLiam G Glynn, Andrew O Regan, Monica Casey, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 20, 2015
Neomorphic effects of recurrent somatic mutations in Yin Yang 1 in insulin-producing adenomasM Kyle Cromer, Murim Choi, Carol Nelson-Williams, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 14, 2006
WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activityKaren L Marquis, Annmarie L Sabb, Sheree F Logue, et al.
Pageof 6